News-Medical.Net on MSN
Investigational anti-clotting drug reduces risk of second ischemic stroke without bleeding concerns
An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic ...
BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...
Parents on MSN
1 in 4 kids who have a concussion will have prolonged symptoms—what parents need to know
A new study looks at how concussions impact kids long after they get one. Experts share what to look out for.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results